Logo image
Steroids and injury to the developing brain: net harm or net benefit?
Journal article   Open access   Peer reviewed

Steroids and injury to the developing brain: net harm or net benefit?

Shadi N Malaeb and Barbara S Stonestreet
Clinics in perinatology, v 41(1), pp 191-208
Mar 2014
PMID: 24524455
url
https://europepmc.org/articles/pmc5083968View
Accepted (AM)Open Access (License Unspecified) Open

Abstract

Brain - drug effects Brain - growth & development Bronchopulmonary Dysplasia - drug therapy Female Glucocorticoids - therapeutic use Humans Infant, Newborn Infant, Premature Neuroprotective Agents - therapeutic use Pregnancy Time Factors
Deleterious effects result from both glucocorticoid insufficiency and excess glucocorticoid tissue exposure in the developing brain. Accumulating evidence suggests a net benefit of postnatal glucocorticoid therapy when administered shortly after the first week of life to premature infants with early and persistent pulmonary dysfunction, particularly in those with evidence of relative adrenal insufficiency. The decision to treat with steroids should ensure maximum respiratory benefit at the lowest possible neurologic risk, while avoiding serious systemic complications. Ongoing clinical trials must validate this approach.

Metrics

13 Record Views
47 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Obstetrics & Gynecology
Pediatrics
Logo image